Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Chord Energy enters the week before its November 4 earnings with a cluster of insider sales on the tape, even as sell-side analysts have spent the past fortnight raising targets and short sellers tentatively rebuild positions.
The insider selling is the sharpest signal in this snapshot. Net disposals over the past 90 days total roughly 47,700 shares worth just under $6.9 million, with no open-market purchases to offset them. CEO Daniel Brown sold more than 13,600 shares across three transactions in late August at prices around $150 to $152, pocketing roughly $1.6 million. Director Samantha McKinney followed in September with a further $1.5 million in sales. None of the filings declare a 10b5-1 pre-arranged plan, which makes each transaction a discretionary decision rather than a scheduled one. The stock has since drifted to $136.05, about 10% below the prices those insiders received.
The short positioning picture has edged in the opposite direction from last week's note. Short interest ticked up 1.4% over the past week to 6.5% of the free float, reversing some of the covering move described in the September 30 article. On a 30-day view the position is up 16%, driven largely by a mid-September build above 4.2 million shares before a partial cover. The borrow market remains entirely unconstrained: availability runs at roughly 1,444%, meaning there are more than 14 shares available to lend for every one already borrowed, and the cost to borrow has fallen to just 0.36%, down 25% on the week. With borrow this cheap and plentiful, any short rebuilding is a deliberate directional call rather than a mechanically squeezed position. Options are leaning slightly bullish, with the put/call ratio at 0.64, a touch below its 20-day average of 0.69 and well clear of the elevated readings above 0.86 that persisted through most of August and early September.
The Street has been pulling targets higher, even as the stock lags. UBS lifted its target to $193 from $184 on October 6, maintaining a Buy. Mizuho moved to $179 from $175 on October 5, also keeping Outperform. Both moves follow a broader round of upgrades in mid-September, when Jefferies, Truist and Citigroup all raised numbers after the stock pulled back. The mean price target now sits at $174.44, implying roughly 28% upside to the current price. The analyst sentiment factor scores in the 96th percentile, reflecting the breadth of positive recommendations relative to the universe. Bulls point to scale in the Williston Basin, low leverage, the pending $550 million Marcellus asset sale, and an estimated 18.6% free cash flow yield in 2026. Bears counter that single-basin exposure leaves the story vulnerable to pipeline, regulatory and pricing shocks, and that the Q1 trough in production, driven by winter disruption and fewer new wells, could pressure near-term metrics. Valuation is not stretched: EV/EBITDA runs at 3.1 times, price/earnings at 7.6 times, and price/book below 1, though that last multiple has drifted down about 10% over the past month.
Ownership is concentrated but stable. BlackRock holds 12.9% of shares, with FMR and Wellington each near 5.8%. Invesco added 876,000 shares in the most recently reported period, the largest incremental move among top holders. There are no 13D activist filers on the register; all holders are passive 13G filers, and the disclosure caveat applies: positions are as-last-disclosed around the 5% threshold.
Wikipedia attention for the stock registered a z-score of 2.1 relative to its own 90-day history as of late September, the highest retail-attention reading in the dataset. That is a measure of interest, not a revenue signal, but it coincides with the stock's dip to multi-month lows and the round of analyst upgrades.
With earnings on November 4, the next four weeks will test whether the Street's raised targets hold against Q3 production numbers and any update on the Marcellus asset sale timeline.
See the live data behind this article on ORTEX.
Open CHRD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
